Both in Pharmaceuticals
Savara vs Rigel Pharmaceuticals Inc. (New)
Over the past year SVRA returned +11.2% and RIGL returned +59.4%; their daily moves had a correlation of 0.24.
SVRA +11.2% RIGL +59.4%Growth of $1, one year, split-adjusted
| Metric | SVRA | RIGL |
|---|---|---|
| Price | $4.75 | $48.86 |
| Market cap | $975.9M | $912.7M |
| Today | +0.42% | −3.31% |
| 1 month | −0.6% | +2.2% |
| 6 months | −9.5% | +73.9% |
| Year to date | −21.2% | +14.1% |
| 1 year | +14.5% | +54.7% |
| Revenue growth (YoY) | — | −22.6% |
| Gross margin | — | 89.2% |
| Net margin | — | 22.0% |
| P/E (TTM) | — | 2.8× |
| Price / sales | — | 3.3× |
| Net cash | $142.9M | $56.1M |
| Dividend yield | — | — |
| Volatility (60d) | 48.5% | 36.6% |
| Short % of float | 20.1% | 16.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).